Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

The FTC sued Cigna-owned Express Scripts, CVS-owned Caremark and UnitedHealth-owned Optum Rx in September, arguing that the drug middlemen prefer more expensive insulin products because they result in ...

A group of independent pharmacies is suing Cigna-owned Express Scripts for allegedly colluding with rival pharmacy benefit manager Prime Therapeutics. The proposed class action lawsuit filed in ...

Advocates for lower drug prices say a federal lawsuit filed this month against St Louis-based Express Scripts and two other companies could result in more affordable medicine for patients. The Federal ...

A handful of independent pharmacies is suing Express Scripts for allegedly signing a three-year deal with pharmacy benefit manager Prime Therapeutics to fix reimbursement rates, a violation of the ...

May 1 (Reuters) - Regeneron Pharmaceuticals and Sanofi will cut the net price of their expensive cholesterol drug for Express Scripts customers in exchange for greater patient access, with some ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, addressing allegations of inflated drug prices and rebate-driven formulary exclusions. The agreement bans the PBM ...

Members with employer-sponsored insurance saw about a 1% decrease in out-of-pocket costs for their prescription medicines last year, paying an average of $15.10 for a 30-day supply "Express Scripts ...

Several independent pharmacies have filed suit against pharmacy benefit management giant Express Scripts, alleging that the company colluded with Prime Therapeutics to fix reimbursement rates. The ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. The state of Michigan is suing two of the nation’s largest ...

The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say has made the price of insulin soar for patients with diabetes. Three ...

On February 4, 2026, the Federal Trade Commission (FTC) proposed to settle its enforcement action against leading pharmacy benefit manager (PBM) Express Scripts, going beyond the insulin products that ...